Member Info for johnlaycock

Roger , you constantly sound like a bitter ex holder who is panicking that they have sold too early ahead of a rise. Oh wait , you have.

The original publication date was 1st Oct and it was put back to 17th Oct on Oct 3rd, so hopefully no more delays.

That's why I think Genedrive is such an attractive takeover target being at the forefront and start of genomic testing.

Report due out Oct 17th.

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

I hope Rogers answer is more positive!

Roger, if he wants to take it private what do you think he will need to pay??

The huge media profile of genetic testing of babies today can only be positive for the company.

Did you read the RNS on the NICE recommendation? It clearly states that the stroke test can be used in Lab settings so it's a win / win either way!!!

Sorry to have interrupted your homework but the company's test cam be used in lab settings so they can sell both to labs and also to the NHS direct as PCT. Win/win.

It's a good thing then Slacker we can sell the test to Labs then! Win/win.

I am not sure the parents whose babies have been spared a life of deafness would say the company is a complete and utterly disaster, no so the stroke victims who have and will continue to benefit from the companies stroke test.

It's difficult to say either way re the two CEXs. James Cheek talked a good game but what did he actually sell before he left? Brighton, I think that was it. Re Gino, it's far too early to make an assessment of his commercial success . Time will tell.

Much as I would like a cash take over, the fact the Chair bought 1m shares recently suggests its not a realistic near term prospect.

Let's not forget the companies test can be used effectively in a lab setting so hopefully they are also selling to Labs as well as direct to the NHS.

Stocksaint - the Sept sales discussion has always been fake news. The company has never mentioned Sept as a sales point in any of their comms.

JH...no as specialist commissioning will happen well before then.

1200 hospitals? That just shows the compelling market the company has in front of it. News flow to come in the next few weeks.

Roger , you keep saying the SP will keep dropping (earlier in the week you said it would be at 1.5p placing price today) but you also say you hold 1.6m shares. The question is why would you keep holding if you think the SP is going back to the placing price? That doesn't make any sense. Sell now and buy back at the placing price if you think that's where it is heading???

Https://poctinnovators.com/roches-acquisition-of-lumiradx-will-supercharge-near-patient-testing/

It was the Chair not the CEX who recently bought 1m shares.